SEARCH

SEARCH BY CITATION

References

  • 1
    De Leeuw AM, McCarthy SP, Geerts A, Knook DL. Purified rat liver fat-stroing cells in culture divide and contain collagen. Hepatology. 1984; 4: 392403.
  • 2
    Weiskirchen R, Gressner AM. Isolation and culture of hepatic stellate cells. Methods Mol Med. 2005; 117: 99113.
  • 3
    Geerts A, Niki T, Hellemans K, De Craemer D, Van Den Berg K, Lazou JM, Stange G, Van De Winkel M, De Bleser P. Purification of rat hepatic stellate cells by side scatter-activated cell sorting. Hepatology. 1998; 27: 5908.
  • 4
    Friedman SL, Rockey DC, McGuire RF, Maher JJ, Boyles JK, Yamasaki G. Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology. 1992; 15: 23443.
  • 5
    Blazejewski S, Preaux AM, Mallat A, Brocheriou I, Mavier P, Dhumeaux D, Hartmann D, Schuppan D, Rosenbaum J. Human myofibroblastlike cells obtained by outgrowth are representative of the fibrogenic cells in the liver. Hepatology. 1995; 22: 78897.
  • 6
    Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol. 2001; 161: 1151.
  • 7
    Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis. 2001; 21: 31135.
  • 8
    Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-_ as major players and therapeutic targets. J Cell Mol Med. 2006; 10: 7699.
  • 9
    Herbst H, Frey A, Heinrichs O, Milani S, Bechstein WO, Neuhaus P, Schuppan D. Heterogeneity of liver cells expressing procollagen types I and IV in vivo. Histochem Cell Biol. 1997; 107: 399409.
  • 10
    Zou Z, Ekataksin W, Wake K. Zonal and regional differences identified from precision mapping of vitamin A-storing lipid droplets of the hepatic stellate cells in pig liver: a novel concept of addressing the intralobular area of heterogeneity. Hepatology. 1998; 27: 1098108.
  • 11
    Knittel T, Kobold D, Saile B, Grundmann A, Neubauer K, Piscaglia F, Ramadori G. Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology. 1999; 117: 120521.
  • 12
    Magness ST, Bataller R, Yang L, Brenner DA. A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology. 2004; 40: 11519.
  • 13
    Kordes C, Sawitza I, Müller-Marbach A, Ale-Agha N, Keitel V, Klonowski-Stumpe H, Häussinger D. CD133+ hepatic stellate cells are progenitor cells. Biochem Biophys Res Commun. 2007; 352: 4107.
  • 14
    Kristensen DB, Kawada N, Imamura K, Miyamoto Y, Tateno C, Seki S, Kuroki T, Yoshizato K. Proteome analysis of rat hepatic stellate cells. Hepatology. 2000; 32: 26877.
  • 15
    Borojevic R, Monteiro AN, Vinhas SA, Domont GB, Mourao PA, Emonard H, Grimaldi G Jr, Grimaud JA. Establishment of a continuous cell line from fibrotic schistosomal granulomas in mice livers. In vitro Cell Dev Biol. 1985; 21: 38290.
  • 16
    Guma FCR, Mello TG, Mermelstein CS, Fortuna VA, Wofchuk ST, Gottfried C, Guaragna RM, Costa ML, Borojevic R. Intermediate filaments modulation in an in vitro model of the hepatic stellate cell activation or conversion into the lipocyte phenotype. Biochem Cell Biol. 2001; 79: 40917.
  • 17
    Mermelstein CS, Guma FC, Mello TG, Fortuna VA, Guaragna RM, Costa ML, Borojevic R. Induction of the lipocyte phenotype in murine hepatic stellate cells: reorganisation of the actin cytoskeleton. Cell Tissue Res. 2001; 306: 7583.
  • 18
    Horie S, Kitamura Y, Kawasaki H, Terada T. Inhibitory effects of antisense oligonucleotides on the expression of procollagen type III gene in mouse hepatic stellate cells transformed by simian virus 40. Pathol Int. 2000; 50: 93744.
  • 19
    Kitamura Y, Tanigawa T, Katsumoto T, Tomita K, Wang HR, Hirai K, Ichihara K, Terada T. Cell growth and differentiation of a novel mouse Ito (fat-storing) cell line transformed by a temperature-sensitive mutant of simian virus 40. Hepatology. 1997; 26: 3239.
  • 20
    Proell V, Mikula M, Fuchs E, Mikulits W. The plasticity of p19 ARF null hepatic stellate cells and the dynamics of activation. Biochim Biophys Acta. 2005; 1744: 7687.
  • 21
    Matsuura T, Kawada M, Sujino H, Hasumura S, Nagamori S, Shimizu H. Vitamin A metabolism of immortalized hepatic stellate cells in the bioreactor. In: WisseE, KnookDL, De ZangerR, ArthurMJP, editors. Cells of the Hepatic Sinusoid 7. Leiden : Kupffer Cell Foundation; 1999. pp. 8889.
  • 22
    Vogel S, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL, Blaner WS. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res. 2000; 41: 88293.
  • 23
    Greenwel P, Schwartz M, Rosas M, Peyrol S, Grimaud JA, Rojkind M. Characterization of fatstoring cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin- 6. Lab Invest. 19991; 65: 64453.
  • 24
    Greenwel P, Rubin J, Schwartz M, Hertzberg EL, Rojkind M. Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43. Lab Invest. 1993; 69: 2106.
  • 25
    Sauvant P, Sapin V, Abergel A, Schmidt CK, Blanchon L, Alexandre-Gouabau MC, Rosenbaum J, Bommelaer G, Rock E, Dastugue B, Nau H, Azais-Braesco V. PAV-1, a new rat hepatic stellate cell line converts retinol into retinoic acid, a process altered by ethanol. Int J Biochem Cell Biol. 2002; 34: 101729.
  • 26
    Sauvant P, Abergel A, Partier A, Alexandre-Gouabau MC, Rock E, Sion B, Motta C, Sapin V, Azais-Bresco V. Treatment of the rat hepatic stellate cell line, PAV-1, by retinol and palmitic acid leads to a convenient model to study retinoids metabolism. Biol Cell. 2002; 94: 4018.
  • 27
    Pan Q, Li DG, Lu HM, Wang YQ, Zhang WZ, Xu QF. A new immortalized rat cell line, hepatic stellate cell-PQ, exhibiting characteristics of hepatic stellate cell. Hepatobiliary Pancreat Dis Int. 2005; 4: 2814.
  • 28
    Xiong S, Yavrom S, Hazra S, Wu D, She H. Spontaneously immortalized cell line from rat liver fibrosis with phenotypes of both hepatic stellate cells and myofibroblasts. Hepatology 2001; 34: 520A.
  • 29
    Sung SK, She H, Xiong S, Tsukamoto H. Tumor necrosis factor-_ inhibits peroxisome proliferator-activated receptor _ activity at a posttranslational level in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2003; 286: G7229.
  • 30
    Isono M, Soda M, Inoue A, Akiyoshi H, Sato K. Reverse transformation of hepatic myofibroblast-like cells by TGF_1/LAP. Biochem Biophys Res Commun. 2003;311: 95965.
  • 31
    Kim JY, Kim KM, Nan JX, Zhao YZ, Park PH, Lee SJ, Sohn DH. Induction of apoptosis in transhinone I via cytochrome c release in activated hepatic stellate cells. Pharmacol & Toxicol. 2003; 92: 195200.
  • 32
    Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y, Inoue K. Differential regulation of TGF-_ signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology. 2002; 35: 4961.
  • 33
    Rao HY, Wei L, Fei R, Wang JH, Jiang D, Zhang Q, Cong X. Inhibitory effect of interferon-_ on the activation of LX-2 and rHSC-99 hepatic stellate cells in culture. Zhonghua Gan Zang Bing Za Zhi. 2006; 14: 5502.
  • 34
    Murakami K, Abe T, Miyazawa M, Yamaguchi M, Masuda T, Matsuura T, Nagamori S, Takeuchi K, Abe K, Kyogoku M. Establishment of a new human cell line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells. Lab Invest. 1995; 72: 7319.
  • 35
    Shibata N, Watanabe T, Okitsu T, Sakaguchi M, Takesue M, Kunieda T, Omoto K, Yamamoto S, Tanaka N, Kobayashi N. Establishment of an immortalized human hepatic stellate cell line to develop antifibrotic therapies. Cell Transplant. 2003; 12: 499507.
  • 36
    Watanabe T, Shibata N, Westerman KA, Okitsu T, Allain JE, Sakaguchi M, Totsugawa T, Maruyama M, Matsumura T, Noguchi H, Yamamoto S, Hikida M, Ohmori A, Reth M, Weber A, Tanaka N, Leboulch P, Kobayashi N. Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers. Transplantation. 2003; 75: 187380.
  • 37
    Weill FX, Blazejewski S, Blanc JF, Huet S, Gauthier JM, Neaud V, Olaso E, Dubuisson L, Azais-Braesco V, Vidal-Vanaclocha F, Balabaud C, Bioulac-Sage P, Rosenbaum J. Characterization of a new human liver myofibroblast cell line: transcriptional regulation of plasminogen activator inhibitor type I by transforming growth factor beta 1. Lab Invest. 1997; 77: 6370.
  • 38
    Schnabl B, Choi YH, Olsen JC, Hagedorn CH, Brenner DA. Immortal activated human hepatic stellate cells generated by ectopic telomerase expression. Lab Invest. 2002; 82: 32333.
  • 39
    Xu L, Hui AY, Albanis E, Arthur MJ, O’Byrne SM, Blaner WS, Mukherjee P, Friedman SL, Eng FJ. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut. 2005; 54: 14251.
  • 40
    González-Cuevas J, Bueno-Topete M, Armendariz-Borunda. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue. J Gastroenterol Hepatol 2006; 21: 154454.
  • 41
    Schnabl B, Purbeck CA, Choi YH, Hagedorn CH, Brenner D, Schnabl B, Purbeck CA, Choi YH, Shibata N, Watanabe T, Okitsu T, Sakaguchi M, Takesue M, Kunieda T, Omoto K, Yamamoto S, Tanaka N, Kobayashi N. Establishment of an immortalized human hepatic stellate cell line to develop antifibrotic therapies. Cell Transplant. 2003; 12: 499507.
  • 42
    Schnabl B, Purbeck CA, Choi YH, Hagedorn CH, Brenner D. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology. 2003; 37: 65364.
  • 43
    Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000; 275: 224750.
  • 44
    Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. Roles of TGF-_ in hepatic fibrosis. Front Biosci. 2002; 7: d793807.
  • 45
    Senoo H, Imai K, Sato M, Kojima N, Miura M, Hata RI. Three-dimensional structure of extracellular matrix reversibly regulates morphology, proliferation, and collagen metabolism of perisinusoidal stellate cells (Vitamin A-storing cells). Cell Biol Int. 1996; 20: 50112.
  • 46
    Sohara N, Znoyko I, Levy MT, Trojanowska M, Reuben A. Reversal of activation of human myofibroblast- like cells by culture on a basement membrane- like substrate. J Hepatol. 2002; 37: 21421.
  • 47
    Weiskirchen R, Kneifel J, Weiskirchen S, Van De Leur E, Kunz D, Gressner AM. Comparative evaluation of gene delivery devices in primary cultures of rat hepatic stellate cells and rat myofibroblasts. BMC Cell Biol. 2000; 1: 4.
  • 48
    Ueki N, Ohkawa T, Yamamura H, Takahashi K, Tsutsui T, Kawai Y, Yokoyama Y, Amuro Y, Hada T, Higashino K. Induction of calponin-h1 by transforming growth factor-_1 in cultured human Ito cells, LI90. Biochim Biophys Acta. 1998; 1403: 2836.
  • 49
    Tang M, Potter JJ, Mezey E. Leptin enhances the effect of transforming growth factor _ in increasing type I collagen formation. Biochem Biophys Res Commun. 2002; 297: 90611.
  • 50
    Dooley S, Delvoux B, Lahme B, Mangasser-Stephan K, Gressner AM. Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology. 2000; 31: 1094106.
  • 51
    Dooley S, Delvoux B, Streckert M, Bonzel L, Stopa M, Ten Dijke P, Gressner AM. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGF_ signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett. 2001; 502: 410.
  • 52
    Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest. 1989; 84: 178693.
  • 53
    Borkham-Kamphorst E, Van Roeyen CR, Ostendorf T, Floege J, Gressner AM, Weiskirchen R. Pro-fibrogenic potential of PDGF-D in liver fibrosis. J Hepatol. 2007; 46: 106474.
  • 54
    Bachem MG, Riess U, Gressner AM. Liver fat-storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor β and inhibited by transforming growth factor β. Biochem Biophys Res Commun. 1989; 162: 70814.
  • 55
    Westhoff JH, Sawitza I, Keski-Oja J, Gressner AM, Breitkopf K. PDGF-BB induces expression of LTBP-1 but not TGF-β 1 in a rat cirrhotic fat storing cell line. Growth Factors. 2003; 21: 12130.
  • 56
    Inagaki Y, Truter S, Greenwel P, Rojkind M, Unoura M, Kobayashi K, Ramirez F. Regulation of the alpha 2(I) collagen gene transcription in fat-storing cells derived from a cirrhotic liver. Hepatology. 1995; 22: 5739.
  • 57
    Garcia-Trevijano ER, Iraburu MJ, Fontana L, Dominguez-Rosales JA, Auster A, Covarrubias-Pinedo A, Rojkind M. Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbetadependent mechanism in rat hepatic stellate cells. Hepatology. 1999; 29: 96070.
  • 58
    Herrmann J, Borkham-Kamphorst E, Haas U, Van de Leur E, Fraga MF, Esteller M, Gressner AM, Weiskirchen R. The expression of CSRP2encoding the LIM domain protein CRP2 is mediated by TGF-_ in smooth muscle and hepatic stellate cells. Biochem Biophys Res Commun. 2006; 345: 152635.
  • 59
    Zhang YP, Yao XX, Zhao X. Interleukin-1 _ up-regulates tissue inhibitor of matrix metalloproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells. World J Gastroenterol. 2006; 12: 13926.
  • 60
    Inagaki Y, Nemoto T, Kushida M, Sheng Y, Higashi K, Ikeda K, Kawada N, Shirasaki F, Takehara K, Sugiyama K, Fujii M, Yamauchi H, Nakao A, De Crombrugghe B, Watanabe T, Okazaki I. Interferon alfa down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology. 2003; 38: 8909.
  • 61
    Iraburu MJ, Dominguez-Rosales JA, Fontana L, Auster A, Garcia-Trevijano ER, Covarrubias-Pinedo A, Rivas-Estilla AM, Greenwel P, Rojkind M. Tumor necrosis factor alpha down-regulates expression of the alpha1(I) collagen gene in rat hepatic stellate cells through a p20 C/EBPbeta- and C/EBPdelta-dependent mechanism. Hepatology. 2000; 31: 108693.
  • 62
    Zhang M, Zhang JP, Ji HT, Wang JS, Qian DH. Effect of six flavonoids on proliferation of hepatic stellate cells in vitro. Acta Pharmacol Sin. 2000; 21: 2536.
  • 63
    Song YH, Zhou XM, Xue XN, Liu NZ, Tian DA, Kong XJ, Wu XL, Lin JS, Jin YX. Effect of ribozyme against transforming growth factor _1 on biological character of activated HSCs. IUBMB Life. 2005; 57: 319.
  • 64
    Liu X, Wang W, Hu H, Tang N, Zhang C, Liang W, Wang M. Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta1 in cultured rat hepatic stellate cells. Pharm Res. 2006; 23: 829.
  • 65
    Gui M, Zhang YF, Xiao ZY, Sun P, Dai JF, Wang SF, Rui YC, Zhang JP. Inhibitory effect of emodin on tissue inhibitor of metalloproteinases-1 (TIMP-1) expression in rat hepatic stellate cells. Dig Dis Sci. 2007; 52: 2007.
  • 66
    Kariv R, Enden A, Zvibel I, Rosner G, Brill S, Shafritz DA, Halpern Z, Oren R. Triiodothyronine and interleukin-6 (IL-6) induce expression of HGF in an immortalized rat hepatic stellate cell line. Liver Int. 2003; 23: 18793.
  • 67
    Ma H, Ma XM, Yin CH, Jia JD, Wang BE. Effects of gamma-interferon on gene expression of collagen I, III and on the tissue inhibitor of metalloprotenase 1 in HSC-T6 cells. Zhonghua Gan Zang Bing Za Zhi. 2005; 13: 52830.
  • 68
    Maubach G, Lim MC, Kumar S, Zhuo L. Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment. Biochim Biophys Acta. 2007; 1773: 21931.
  • 69
    Li X, Meng Y, Cai SX, Yang XS, Zhang YJ, Wu PS. Angiotensin II and aldosterone stimulate alpha1-(I) procollagen mRNA expression in hepatic stellate cells via activation of ERK1/2 and AP-1. Zhonghua Yi Xue Za Zhi. 2005; 85: 18315.
  • 70
    Li X, Meng Y, Yang XS, Wu PS, Zhang ZS. Aldosterone stimulating PDGF-B expression in HSC via activation of EGR-1. Zhonghua Gan Zang Bing Za Zhi. 2005; 13: 56770.
  • 71
    Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania FA. Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology. 2002; 35: 76271.
  • 72
    Margis R, Pinheiro-Margis M, Da Silva LC, Borojevic R. Effects of retinol on proliferation, cell adherence and extracellular matrix synthesis in a liver myofibroblast or lipocyte cell line (GRX). Int J Exp Pathol. 1992; 73: 12535.
  • 73
    Guma FCR, Mello TG, Mermelstein CS, Fortuna VA, Wofchuk ST, Gottfried C, Guaragna RM, Costa ML, Borojevic R. Intermediate filaments modulation in an in vitro model of the hepatic stellate cell activation or conversion into the lipocyte phenotype. Biochem Cell Biol. 2001; 79: 40917.
  • 74
    Zhao C, Chen W, Yang L, Chen L, Stimpson SA, Diehl AM. PPAR_ agonists prevent TGF_1/Smad3- signaling in human hepatic stellate cells. Biochem Biophys Res Commun. 2006; 350: 38591.
  • 75
    Shi YF, Zhang Q, Cheung PY, Shi L, Fong CC, Zhang Y, Tzang CH, Chan BP, Fong WF, Chun J, Kung HF, Yang M. Effects of rhDecorin on TGF-_1 induced human hepatic stellate cells LX-2 activation. Biochim Biophys Acta. 2006; 1760: 158795.
  • 76
    Cao Q, Mak KM, Ren C, Lieber CS. Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells: respective roles of the JAK/STAT and JAK-mediated H2 O2-dependant MAPK pathways. J Biol Chem. 2004; 279: 4292304.
  • 77
    Cao Q, Mak KM, Lieber CS. Leptin enhances _1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2 O2-dependent MAPK pathways. J Cell Biochem. 2006; 97: 18897.
  • 78
    Cao Q, Mak KM, Lieber CS. Leptin represses matrix metalloproteinase-1 gene expression in LX2 human hepatic stellate cells. J Hepatol. 2007; 46: 12433.
  • 79
    Hui AY, Cheng AS, Chan HL, Go MY, Chan FK, Sakata R, Ueno T, Sata M, Sung JJ. Effect of prostaglandin E2 and prostaglandin I2 on PDGFinduced proliferation of LI90, a human hepatic stellate cell line. Prostaglandins Leukot Essent Fatty Acids. 2004; 71: 32933.
  • 80
    Ueki N, Taguchi T, Takahashi M, Adachi M, Ohkawa T, Amuro Y, Hada T, Higashino K. Inhibition of hyaluronan synthesis by vesnarinone in cultured human myofibroblasts. Biochim Biophys Acta. 2000; 1495: 1607.
  • 81
    Sugimoto R, Enjoji M, Nakamuta M, Ohta S, Kohjima M, Fukushima M, Kuniyoshi M, Arimura E, Morizono S, Kotoh K, Nawata H. Effect of IL-4 and IL-13 on collagen production in cultured LI90 human hepatic stellate cells. Liver Int. 2005; 25: 4208.
  • 82
    Kanno K, Tazuma S, Nishioka T, Hyogo H, Chayama K. Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression. Dig Dis Sci. 2005; 50: 9428.
  • 83
    Migita K, Maeda Y, Abiru S, Nakamura M, Komori A, Yokoyama T, Takii Y, Mori T, Yatsuhashi H, Eguchi K, Ishibashi H. Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF- _-stimulated human hepatic stellate cells. Life Sci. 2006; 78: 25105.
  • 84
    Ozaki I, Zhao G, Mizuta T, Ogawa Y, Hara T, Kajihara S, Hisatomi A, Sakai T, Yamamoto K. Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) viathe transcription factor Ets-1 in human hepatic stellate cell line. J Hepatol. 2002; 36: 16978.